Name: Recombinant Anti-M2 x Anti-TCR (Vβ8) Bispecific Antibody (IgG-Fv)
SKU: BSGV-180
Rating: 5 (1 reviews)

Recombinant Anti-M2 x Anti-TCR (Vβ8) Bispecific Antibody (IgG-Fv) is formed by an Immunoglobulin G (IgG) and a fragment variable Fv region, in which the Fc of IgG is engineered by KIH. The Fv region of an anti-M2 antibody variable domain is fused to the C terminal of an IgG of anti-TCR (Vβ8) antibody, or vice versa. The format retains desired characteristics of intact antibodies. This BsAb can retarget T cells to virus-infected cells. It is designed for the research of Inﬂuenza virus infection therapy.

Datasheet INQUIRY

Specifications

Targets

M2 & TCR (Vβ8)

Type

IgG-Fv

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Inﬂuenza virus infection

Host Animal 1

Mouse

Host Animal 2

Mouse

Targets

Target 1

Gene ID

956528

UniProt ID

P03428

Alternative Names

influenza virus M2 protein;M2

Target 2

TCR (Vβ8)

Gene ID

28588

Alternative Names

Trbv8; T cell receptor beta variable 8; TCR; T-cell receptor

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-M2 x Anti-TCR (Vβ8) Bispecific Antibody (IgG-Fv) (BSGV-180). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-M2 x Anti-TCR (Vβ8) Bispecific Antibody (IgG-Fv) (CAT#: BSGV-180)

Specifications

Targets

Customer Reviews and Q&As